China's Industrial Strategy Pivots to AI, Robotics, Biopharma
SHERIDAN, WYOMING -- August 14, 2026 -- A new commentary series from Global Times outlines how China's export and manufacturing strategy is shifting toward a fresh set of priority sectors: artificial intelligence, robotics and innovative medicines. Termed the "next new three," these industries are positioned to follow the earlier "new trio" of electric vehicles, lithium batteries and photovoltaic products, which reshaped China's trade profile over the past several years. The framing matters for international buyers and supply chain planners tracking where Chinese industrial capacity and innovation investment are headed next. It also signals continuity rather than disruption, since the commentary frames this progression as an extension of decades of manufacturing buildout rather than a break from it.